참고문헌
- Banu E, Banu A, Fodor A, et al (2007). Meta-analysis of randomised trials comparing gemcitabine-based doublets versus gemcitabine alone in patients with advanced and metastatic pancreatic cancer. Drugs Aging, 24, 865. https://doi.org/10.2165/00002512-200724100-00006
- Bria E, Milella M, Gelibter A, et al (2007). Gemcitabine based combinations for inoperable pancreatic cancer: Have we made real progress? A meta-analysis of 20 phase 3 trials. Cancer, 110, 525. https://doi.org/10.1002/cncr.22809
- Brunner TB, Scott-Brown M (2010). The role of radiotherapy in multimodal treatment of pancreatic carcinoma. Radiat Oncol, 5, 64. https://doi.org/10.1186/1748-717X-5-64
- Burris HA, Moore MJ, Andersen J, et al (1997). Improvements in survival and clinical benefit with gemcitabine as first-line therapy for patients with advanced pancreas cancer: a randomized trial. J Clin Oncol, 15, 2403-13. https://doi.org/10.1200/JCO.1997.15.6.2403
- Hidalgo M (2010). Pancreatic cancer. N Engl J Med, 362, 1605-17. https://doi.org/10.1056/NEJMra0901557
- Hunter KU, Feng FY, Griffith KA, et al (2011). Radiation therapy with full-dose gemcitabine and oxaliplatin for unresectable pancreatic cancer. Int J Radiat Oncol Biol Phys, 83, 921-6.
- Jemal A, Siegel R, Ward E, et al (2007). Cancer statistics, 2007. CA Cancer J Clin, 57, 43-66. https://doi.org/10.3322/canjclin.57.1.43
- Li D, Xie K, Wolff R, et al (2010). Pancreatic cancer. Lancet, 1363, 1049-57.
- Loehrer PJ Sr, Feng Y, Cardenes H, et al (2011). Gemcitabine alone versus gemcitabine plus radiotherapy in patients with locally advanced pancreatic cancer: an Eastern Cooperative Oncology Group trial. J Clin Oncol, 29, 4105-12. https://doi.org/10.1200/JCO.2011.34.8904
- Ni QX, Fu DL (2006). Combined therapy based on tumor biology characteristic for advanced pancretic cancer. Theory Pract Surg, 11, 471-7.
- Sener SF, Fremgen A (1999). Pancreatic cancer: a report of treatment and survival trends for 100,313 patients diagnosed from 1985-1995, using the National Cancer Database. J Am Coll Surg, 189, 1-7. https://doi.org/10.1016/S1072-7515(99)00075-7
- Sultana A, Smith CT, Cunningham D, et al (2007). Met-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol, 25, 2607. https://doi.org/10.1200/JCO.2006.09.2551
- Zhu CP, Shi J, Chen YX, et al (2011). Gemcitabine in the chemoradiotherapy for locally advanced pancreatic cancer: A meta-analysis. Radiother Oncol, 99, 108-13. https://doi.org/10.1016/j.radonc.2011.04.001
피인용 문헌
- Cryptotanshinone suppresses the proliferation and induces the apoptosis of pancreatic cancer cells via the STAT3 signaling pathway vol.12, pp.5, 2015, https://doi.org/10.3892/mmr.2015.4379
- Longer Course of Induction Chemotherapy Followed by Chemoradiation Favors Better Survival Outcomes for Patients With Locally Advanced Pancreatic Cancer vol.39, pp.1, 2016, https://doi.org/10.1097/COC.0000000000000022
- Chemoradiotherapy versus chemotherapy for locally advanced unresectable pancreatic cancer: A systematic review and meta-analysis pp.17437555, 2018, https://doi.org/10.1111/ajco.12996